Dr Elizabeth L Christie
Peter MacCallum Cancer Institute
Post-Doc, Life Sciences
Australia
My co-authors include
Professor Daniel S. Brewer
Anna Ehinger
TaoBo Hu
My Publications
Inferring structural variant cancer cell fraction
Nature Communications
February 2020
Reconstructing evolutionary trajectories of mutation signature activities in cancer usi...
Nature Communications
February 2020
Pan-cancer analysis of whole genomes
Nature
February 2020
The evolutionary history of 2,658 cancers
Nature
February 2020
Pooled genomic screens identify anti-apoptotic genes as targetable mediators of chemoth...
Molecular Cancer Research
August 2019
TARGETING MULTIDRUG RESISTANCE PROTEIN 1 (MDR1) POTENTIATES SMAC-MIMETIC THERAPY TO KIL...
Experimental Hematology
August 2019
Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and ...
Nature Communications
March 2019
Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer
Hematology/Oncology Clinics of North America
December 2018
Ovarian Carcinoma-Associated Mesenchymal Stem Cells Arise from Tissue-Specific Normal S...
Stem Cells
November 2018
Neutral tumor evolution?
Nature Genetics
October 2018
Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer
BMC Cancer
January 2018
Acquired chemotherapy resistance in ovarian cancer
Annals of Oncology
November 2017
Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss ...
Clinical Cancer Research
October 2017
EIF1AX and NRAS Mutations Co-occur and...
Cancer Research
June 2017
Reversion of BRCA1/2 Germline Mutations Detected in Circulating Tumor DNA From Patients...
Journal of Clinical Oncology
April 2017
Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer
November 2016
Blood Worth Bottling: Circulating Tumor DNA as a Cancer Biomarker
Cancer Research
October 2016
A community-based model of rapid autopsy in end-stage cancer patients
Nature Biotechnology
September 2016
Corrigendum: Whole–genome characterization of chemoresistant ovarian cancer
Nature
October 2015
Whole–genome characterization of chemoresistant ovarian cancer
Nature
May 2015
LRP1B Deletion in High-Grade Serous Ovarian Cancers Is Associated with Acquired Chemoth...
Cancer Research
August 2012
Abnormal Nuclear Pore Formation Triggers Apoptosis in the Intestinal Epithelium of elys...
Gastroenterology
March 2009
Determination of mRNA and Protein Expression Patterns in Zebrafish
January 2008